Sort
30,917 grants matching “tumor microenvironment”
Omic and Multidimensional Spatial Atlas of Metastatic Breast and Prostate Cancers
$1,747,063Emek Demir · Oregon Health & Science University · U2C · FY2022 · CA
exRNA in colorectal carcinoma: biogenesis and function
$1,745,733Alissa M Weaver · Vanderbilt University · P01 · FY2022 · CA
The stromal microenvironment as a co-organizer of bladder carcinogenesis and progression
$1,745,043Keith Syson Chan · Cedars-Sinai Medical Center · U54 · FY2022 · CA
exRNA in colorectal carcinoma: biogenesis and function
$1,745,006Alissa M Weaver · Vanderbilt University · P01 · FY2023 · CA
New Surgical Approaches For The Management Of Malignant Melanoma
$1,742,973Donald L Morton · Saint John'S Cancer Institute · P01 · FY2013 · CA
Identification and Characterization of Signaling Pathways and Mediators Regulating Mast Cell-Related Disorders
$1,739,294Ana Olivera · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Human EGFRvIII-specific BiTE for the treatment of Glioblastoma
$1,736,476John H Sampson · Duke University · U01 · FY2017 · NS
Center for Cancer Systems Therapeutics (CaST)
$1,736,052Andrea Califano · Columbia University Health Sciences · U54 · FY2024 · CA
Phenotype Heterogeneity and Dynamics in SCLC
$1,735,466Vito Quaranta · Vanderbilt University · U54 · FY2019 · CA
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases
$1,734,905Patrizia Farci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Precision Medicine of Cancer
$1,733,722Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Phenotype Heterogeneity and Dynamics in SCLC
$1,732,985Vito Quaranta · Vanderbilt University · U54 · FY2020 · CA
Pathobiology Of Uterine Leiomyomas (fibroids)
$1,731,216Darlene Dixon · National Institute Of Environmental Health Sciences · ZIA · FY2022 · ES
Shaping of the Microenvironment in Colonic Pre-Cancer by Epithelia and Microbiota
$1,730,379Martha J. Shrubsole · Vanderbilt University Medical Center · U54 · FY2022 · CA
SPORE in Breast Cancer
$1,725,265Charles M Perou · Univ Of North Carolina Chapel Hill · P50 · FY2016 · CA
Development of a Novel Resolvin-Based Therapy for Treatment of Pancreatic Cancer
$1,725,203John Parkinson · Thetis Pharmaceuticals, Llc · R44 · FY2025 · CA
Cytokine and immunotherapy in cancer and AIDS
$1,725,137Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Modulating BBB Permeability in Malignant Glioma
$1,724,894Sadhana Jackson · National Institute Of Neurological Disorders And Stroke · ZIA · FY2024 · NS
Omic and Multidimensional Spatial Atlas of Metastatic Breast and Prostate Cancers
$1,723,236Jeremy Goecks · Oregon Health & Science University · U2C · FY2021 · CA
The Physical Microenvironment in Cancer Biology and Therapy
$1,722,271Robert A Gatenby · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2013 · CA
Circumventing Barriers to Effective Oncolytic Virotherapy of Malignant Gliomas
$1,721,925Michael A Caligiuri · Ohio State University · P01 · FY2013 · CA
Genome Instability Induced Anti-Tumor Immune Responses
$1,717,973Roger A Greenberg · University Of Pennsylvania · P01 · FY2025 · CA
Center for 3D Imaging in Cancer Cell Biology
$1,717,953Denis Wirtz · Johns Hopkins University · U54 · FY2022 · CA
Single Cell Analysis Facility
$1,717,697Michael Kelly · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA
Circumventing barriers to effective oncolytic virotherapy of malignant gliomas
$1,717,653E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2019 · CA